PURA VIDA INVESTMENTS, LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.

Quarter-by-quarter ownership
PURA VIDA INVESTMENTS, LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$2,019,000
-90.4%
25,850
-79.2%
0.06%
-91.5%
Q4 2020$21,141,000
+178.8%
124,000
+129.6%
0.77%
+96.7%
Q3 2020$7,583,000
-74.2%
54,000
-70.6%
0.39%
-86.2%
Q2 2020$29,406,000
+67.6%
183,400
+2.2%
2.83%
+35.7%
Q1 2020$17,549,000
+24.8%
179,400
+64.6%
2.08%
+68.5%
Q4 2019$14,065,000
+86.7%
109,000
+9.0%
1.24%
-3.9%
Q3 2019$7,532,000
+256.1%
100,000
+525.0%
1.29%
+51.8%
Q2 2018$2,115,000
-6.7%
16,000
-68.0%
0.85%
+27.7%
Q3 2017$2,268,000
+124.3%
50,000
+66.7%
0.66%
+65.6%
Q2 2017$1,011,000
-58.8%
30,000
-25.0%
0.40%
-46.2%
Q3 2016$2,456,000
+25.8%
40,000
-60.0%
0.75%
-16.0%
Q1 2016$1,952,000
+838.5%
100,000
+1751.9%
0.89%
+909.1%
Q4 2015$208,000
+20.2%
5,4000.0%0.09%
-11.1%
Q3 2015$173,000
+5.5%
5,4000.0%0.10%
+17.9%
Q2 2015$164,000
+127.8%
5,4000.0%0.08%
+127.0%
Q1 2015$72,0005,4000.04%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Perceptive Advisors 2,878,979$69,182,0007.27%
Eventide Asset Management 259,100$6,226,0000.97%
GLADE BROOK CAPITAL PARTNERS LLC 251,000$6,032,0000.93%
IMS Capital Management 32,215$774,0000.91%
Perceptive Advisors 350,000$8,413,0000.88%
Benchmark Capital Advisors 34,900$839,0000.58%
BECK CAPITAL MANAGEMENT, LLC 24,744$636,0000.49%
SABBY MANAGEMENT, LLC 352,100$8,461,0000.47%
Hatteras Alternative Mutual Funds, LLC 39,404$947,0000.46%
Potomac Capital Management, Inc. 22,100$531,0000.45%
View complete list of SAREPTA THERAPEUTICS INC shareholders